Haleon share price slides on softer 2026 growth view as buyback fails to calm investors
Haleon shares dropped 4% to 389.30 pence in early London trading after the company forecast slower 2026 organic revenue growth of 3–5%, below its medium-term target. The Sensodyne maker cited weak U.S. demand and a mild cold-and-flu season. 2025 revenue slipped 1.8% to £11.03 billion. Haleon plans a £500 million buyback and proposed a 7.1 pence dividend.